Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
TISAGENLECLEUCEL 0.2X10EXP6 TO 2.5X10EXP8 CELL IV SUSP (OTHER RX-180613) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 29, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-180613/by-state?code_type=OTHER
“TISAGENLECLEUCEL 0.2X10EXP6 TO 2.5X10EXP8 CELL IV SUSP (OTHER RX-180613) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-180613/by-state?code_type=OTHER. Accessed
June 29, 2026 .
“TISAGENLECLEUCEL 0.2X10EXP6 TO 2.5X10EXP8 CELL IV SUSP (OTHER RX-180613) by State,” HANK Price Transparency ,
accessed June 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-180613/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
RX-180613 — Tisagenlecleucel 0.2x10exp6 To 2.5x10exp8 Cell IV Susp
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,745,686
National median
$578,325 – $2,688,357
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-180613 (OTHER), with interquartile range
State Median p25 p75
LA $1,745,686 $578,325 $2,688,357